RAPT THERAPEUTICS INC (RAPT)
US75382E1091 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to RAPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.59. This target is 202.4% above the current price.
RAPT was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about RAPT.
In the previous month the buy percentage consensus was at a similar level.
RAPT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-22 | UBS | Downgrade | Buy -> Neutral |
| 2024-02-21 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-21 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-21 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-02-21 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-02-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-02-16 | Evercore ISI Group | Initiate | Outperform |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-14 | Berenberg | Initiate | Buy |
| 2023-08-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | Stifel | Initiate | Buy |
| 2023-06-15 | Barclays | Initiate | Overweight |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-21 | JP Morgan | Maintains | Overweight |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-15 | Guggenheim | Maintains | Buy |
| 2023-03-15 | Goldman Sachs | Maintains | Buy |
| 2023-03-15 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-04 | Guggenheim | Initiate | Buy |
| 2023-01-04 | Wells Fargo | Maintains | Overweight |
| 2022-12-01 | Goldman Sachs | Initiate | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |